International Consensus Statement on Rhinology and Allergy: Rhinosinusitis

Background: The 5 years since the publication of the first International Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR‐RS) has witnessed foundational progress in our understanding and treatment of rhinologic disease. These advances are reflected within the more than 40 new topics covered within the ICAR‐RS‐2021 as well as updates to the original 140 topics. This executive summary consolidates the evidence‐based findings of the document. Methods: ICAR‐RS presents over 180 topics in the forms of evidence‐based reviews with recommendations (EBRRs), evidence‐based reviews, and literature reviews. The highest grade structured recommendations of the EBRR sections are summarized in this executive summary. Results: ICAR‐RS‐2021 covers 22 topics regarding the medical management of RS, which are grade A/B and are presented in the executive summary. Additionally, 4 topics regarding the surgical management of RS are grade A/B and are presented in the executive summary. Finally, a comprehensive evidence‐based management algorithm is provided. Conclusion: This ICAR‐RS‐2021 executive summary provides a compilation of the evidence‐based recommendations for medical and surgical treatment of the most common forms of RS

Considering the links between non-timber forest products and poverty alleviation

The debates around the value and importance of non-timber forest products (NTFPs) are complex and ongoing. The complexity is a result of many factors, including the wide variety of species, products and uses, as well as the variety of constituencies and disciplines each seeing advantage from ‘co-opting’ the importance of the contribution of NTFPs to their own areas of interest and concern. Conservationists are interested in NTFPs because their combined high value in many settings offers a potential alternative to the destruction of forests by either commercial logging or their widespread conversion to other land uses